Jay Skyler, MD
Enriched profileDeputy Director for Clinical Research and Academic Programs (also referenced as Chief Academic Officer), Diabetes Research Institute; Professor of Medicine, Pediatrics, & Psychology, Division of Endocrinology, Diabetes and Metabolism · Diabetes Research Institute
Jay Skyler is Deputy Director for Clinical Research and Academic Programs (also referenced as Chief Academic Officer), Diabetes Research Institute; Professor of Medicine, Pediatrics, & Psychology, Division of Endocrinology, Diabetes and Metabolism at Diabetes Research Institute. OpenAlex indexes 487 publications with 25,637 citations (h-index 76); ClinicalTrials.gov lists 8 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 1 Sept 2026
Jay Skyler, MD, is Deputy Director for Clinical Research and Academic Programs (also referenced as Chief Academic Officer), Diabetes Research Institute. The public record shows 487 publications with 25,637 citations (h-index 76), centered on Diabetes Management and Research, Diabetes and associated disorders, Pancreatic function and diabetes. It also documents an investigator role on 8 registered clinical trials, industry payments reported by 14 companies, 6 NIH-funded awards (1985–2019).
- Most recent indexed publication: 2026 · Diabetes technology & therapeutics
- Top research focus: Diabetes Management and Research
- 8 registered trials on ClinicalTrials.gov
- Open Payments reporting from 14 companies
Generated from the cited public record · current as of 1 Sept 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 26 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 228.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →statnews.com ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 1 Sept 2026
Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:
- Low-dose IL-2 in Established T1D - The "PROREG" Study
Sponsor: Jay S. Skyler
- Effect of Metabolic Control at Onset of Diabetes on Progression of Type 1 Diabetes
Sponsor: Jaeb Center for Health Research
- Effects of Recombinant Human Glutamic Acid Decarboxylase on the Progression of Type 1 Diabetes in New Onset Subjects
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Industry payments
Updated 1 Sept 2026
14 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- SANOFI US SERVICES INC.Program year20257 payments$23,620openpaymentsdata.cms.gov ↗
- GENZYME CORPORATIONProgram year20255 payments$22,877openpaymentsdata.cms.gov ↗
- Novo Nordisk ASProgram year20256 payments$12,904openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
54.8%Statin54.8%Atorvastatin Calcium100%Part D<11 patientsHormonal (systemic)
45.2%l-Thyroxine45.2%Levothyroxine Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 1 Sept 2026
6 NIH research awards on record, funded 1985–2019 per NIH RePORTER. The latest:
Congress activity
Updated 1 Sept 2026
18 congress contributions (2014–2025) across ADA, ASCO per OpenAlex. The most recent:
- 726-P: Two-Year Follow-up of AVT001 Dendritic Cell Therapy for Type 1 Diabetes—Continued Off-Therapy Functional Effects and Characterization of Responders
ADA Scientific Sessions
ADA2025Co-authorPoster - 875-P: Baseline Characteristics for FINE-ONE—A Randomized Phase III Trial Assessing Finerenone in People with T1D and CKD
ADA Scientific Sessions
ADA2025Co-authorPoster - 20-OR: Loss of Characteristic ß-Cell Function in Autoantibody-Positive (Ab+) Individuals during the Progression to Type 1 Diabetes (T1D)
ADA Scientific Sessions
ADA2023Co-authorOral
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 1 Sept 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Engagement with an AI- and CGM-Integrated Digital Health Platform Is Associated with Clinically Significant Weight Loss.
Diabetes technology & therapeutics
Article2026
Most-cited works
by citation count (OpenAlex)Network
Updated 1 Sept 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 1 Sept 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/jay-skyler-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Other
med.miami.edu/faculty/jay-s-skyler-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗ - ResearchGate
researchgate.net/profile/Jay-Skyler
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
diabetesresearch.org/jay-skyler
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetesresearch.org ↗ - Other
ir.sab.bio/board-member/jay-skyler
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ir.sab.bio ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 1 Sept 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.med.miami.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetesresearch.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
- B.A./B.S.
Pennsylvania State University (undergraduate)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetesresearch.org ↗ - Postgraduate training in Internal Medicine and Endocrinology & Metabolism
Duke University Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
Editorial & leadership roles
journal and society appointments- Former Study Chairman
NIH-sponsored Diabetes Prevention Trial-Type 1 (DPT-1) and successor Type 1 Diabetes TrialNet Clinical Trials Study Group
2015verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetesresearch.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →diabetesresearch.org ↗
- 2023 Fellow of the Royal College of Physicians
United Kingdom (FRCP), inducted October 10, 2023 in London
2023verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.med.miami.edu ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →diabetesresearch.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ir.sab.bio ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →finance.yahoo.com ↗
- Adjunct Professor of Pediatrics
Barbara Davis Center for Childhood Diabetes, University of Colorado Denver
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetesresearch.org ↗
Media & interviews
press, podcasts and appearances- Interview: "Defeating Diabetes"
Diabetes Management journal, December 2014 (Q&A profile of his career and research)
2014verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetesresearch.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.med.miami.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Eric Van Cutsem, MD, PhD
University Hospitals Leuven (UZ Leuven)
Josep Tabernero, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Charles Fuchs, MD, MPH
Tubulis GmbH